IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release with respect to Financial Results for the Quarter and nine months ended 31 December 201812-02-2019
12-02-2019
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Outcome of Board Meeting
Dear Sir, Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on 12 February 2019 has approved the following: 1. Un-audited Financial Results for the Quarter and nine months ended 31 December 2018. 2. Appointment of Mr Rajender Mohan Malla, Independent Director as Chairman of the Board. 3. Re-appointment of Mr Vijay Garg, as Joint Managing Director of the company. 4. Modifications in the Code of Conduct to Regulate, Monitor and Report Trading by Insiders which will take effect from 1 April 2019. 5. Issue of 25,00,000 (Twenty five lakh) convertible warrants on preferential basis to M/s Towel Enterprises Limited, Promoter company at a price of Rs. 205/- per warrant being the price not less than the price determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- for every warrant held, within 18 months from the date of allotment of the warrants. 6. Reclassification of the Authorised Share Capital of the Company from Rs. 80,00,00,000/- (Rupees eighty crore) divided into 2,20,00,000 (Two crore twenty lakh) Preference Shares of Rs. 10/- (Rupees ten) each and 5,80,00,000 (Five crore eighty lakh) Equity Shares of Rs. 10/- (Rupees ten) each to Rs. 80,00,00,000/- (Rupees eighty crore) divided into 8,00,00,000 (Eight crore) Equity Shares of Rs. 10/- (Rupees ten) each. 7. Convening of Extra-ordinary General Meeting of the shareholders...12-02-2019
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Un-Audited Financial Results For The Quarter And Nine Months Ended 31 December 2018
Dear Sir, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing un-audited Financial Results for the Quarter and nine months ended 31 December 2018 as approved by the Board of Directors in its meeting held on 12 February 2019 (12.00 Noon to 3:40 PM) along with Limited Review Report on the Un-audited Financial Results by M/s Ashwani & Associates, Chartered Accountants, Ludhiana, Statutory Auditors of the company. The same is also available on the website of the Company i.e. www.iolcp.com. This is for your information & record please.12-02-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice published in Newspapers06-02-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Change in Management
1. Appointment of Mr Rajender Mohan Malla (DIN 00136657) as Additional and Independent Director for a period of three years with effect from 6 February 2019 subject to the approval of the shareholders. 2. Appointment of Mr Harpal Singh (DIN 06658043) as Additional and Independent Director for a period of three years with effect from 6 February 2019 subject to the approval of the shareholders 3. Reconstitution of committees of board on appointment of independent directors detail attached. This is for your information & record please.06-02-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Closure of Trading Window
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Tuesday, the 12 February 2019 inter-alia to consider issue of securities on preferential basis to the promoters and the un-audited financial results of the Company for the quarter and nine months ended 31 December 2018. Further, in terms of provisions of the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed with immediate effect and will open after 48 hours, the financial results for the quarter and nine months ended 31 December 2018 made public.04-02-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Issue Of Securities On Preferential Basis To The Promoters And The Un-Audited Financial Results
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve issue of securities on preferential basis to the promoters and the un-audited financial results of the Company for the quarter and nine months ended 31 December 2018.04-02-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates/Issue of duplicate share certificates28-01-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Loss of Share Certificate / Issue of Duplicate Share Certificate
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.24-01-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Shareholding for the Period Ended December 31, 2018
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here18-01-2019